Bleeding Endpoints (Included Surgical Site)
Enoxaparin, N = 2659
Apixaban, N = 2673
% of Patients Experiencing
Bleeding Event
15
10
5
0
0.68%
n = 18
0.82%
n = 22*
5.04%
n = 134
4.83%
n = 129
12.56%
n = 334
11.71%
n = 313
Major Bleeding
Major + CRNM Bleeding
All Bleeding
ELIQUIS increases the risk of bleeding and can cause serious, potentially fatal, bleeding